0001171000-15-000070.txt : 20150908
0001171000-15-000070.hdr.sgml : 20150907
20150908142741
ACCESSION NUMBER: 0001171000-15-000070
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150903
FILED AS OF DATE: 20150908
DATE AS OF CHANGE: 20150908
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nexvet Biopharma plc
CENTRAL INDEX KEY: 0001618561
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: NATL INST FOR BIOPROCESSING RESEARCH
STREET 2: FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK CO. DUBLIN
STATE: L2
ZIP: 00000
BUSINESS PHONE: 353 1 215 8100
MAIL ADDRESS:
STREET 1: NATL INST FOR BIOPROCESSING RESEARCH
STREET 2: FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK CO. DUBLIN
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd
DATE OF NAME CHANGE: 20140903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GILES COLIN
CENTRAL INDEX KEY: 0001632546
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36828
FILM NUMBER: 151096282
MAIL ADDRESS:
STREET 1: C/O NEXVET BIOPHARMA PLC, NATL INSTITUTE
STREET 2: FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK
STATE: L2
ZIP: 00000
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-09-03
0001618561
Nexvet Biopharma plc
NVET
0001632546
GILES COLIN
C/O NEXVET BIOPHARMA PLC
NIBRT, FOSTERS AVENUE, MOUNT MERRION
BLACKROCK, CO. DUBLIN
L2
IRELAND
0
1
0
0
VP Clinical&Regulatory Affairs
Restricted Share Units
.125
2015-09-03
4
A
0
16162
0
A
2016-07-01
2020-07-01
Ordinary Shares
16162
16162
D
4,041 of the Restricted Share Units shall vest and become convertible on each of 7/1/16 and 7/1/17 and 4,040 of the Restricted Share Units shall vest and become convertible on each of 7/1/18 and 7/1/19, in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting.
/s/ Colin Giles by Geraldine T. Farrell, Attorney-in-Fact
2015-09-08